Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Qraypen

K-Number: K183121 · 2019-07-18

Decision Date2019-07-18
Product CodeEIA
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Qraypen is the device name listed in this FDA 510(k) record. The listed applicant is AIOBIO Co., Ltd.. It received FDA 510(k) clearance on 2019-07-18 under 510(k) number K183121. The device is classified under product code EIA. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Qraypen?

Qraypen is a medical device that received FDA 510(k) clearance on 2019-07-18. The listed applicant is AIOBIO Co., Ltd.. The 510(k) number is K183121.

When did Qraypen receive FDA 510(k) clearance?

Qraypen received FDA 510(k) clearance on 2019-07-18, under 510(k) number K183121.

Who is the listed applicant for Qraypen?

The FDA 510(k) record lists AIOBIO Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Qraypen?

The FDA product code for Qraypen is EIA.

Other records listing AIOBIO Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: EIA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.